OakChart

Bio-Rad Laboratories Inc

BIOHealthcare·Medical Devices·USA·Large·NYSE·Nov 10 • 3:59 PM ET

386.480.00 (0.00%)
2026-11-11 14:22 CET
Market cap
10,393.57 USD m
Revenue, TTM
2,592.70 USD m
Net income, TTM
1,022.90 USD m
Free cash flow, TTM
329.10 USD m
EPS diluted, TTM
37.97
P/E
10.18
Compare

Price

BIO against its 20, 50 and 200-day averages
2050200earnings
250.00300.00350.00400.00632K1.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BIOclose 386.4820-day 371.1950-day 373.64200-day 315.84386.48

2.5% under 396.23 on 27 Aug 2026. Last 15 sessions, 13.7% high to low

Profile

BIO
52-week range, 94% of the way up
236.73396.23

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

IndexRUI
Employees7450
IPOFeb 27, 1980
Beta1.05
ATR, 14d13.19
Rel volume0.00
Short float6.43%
Insider own33.16%
Inst own71.34%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap10.41B
Enterprise Value10.10B
Income1.02B
Sales2.59B
Book/sh282.73
Cash/sh61.87
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees7450
IPOFeb 27, 1980

Ratios

P/E10.18
Forward P/E36.86
PEG5.96
P/S4.01
P/B1.37
P/C6.25
P/FCF31.62
EV/EBITDA22.46
EV/Sales3.90
Quick Ratio2.37
Current Ratio3.18
Debt/Eq0.18
LT Debt/Eq0.12
Option/ShortYes / Yes

Earnings

EPS (ttm)37.97
EPS next Y10.49
EPS next Q2.83
EPS this Y0.64%
EPS next Y5.03%
EPS next 5Y6.18%
EPS past 3/5Y- -26.08%
Sales past 3/5Y-2.68% 0.29%
EPS Y/Y TTM256.97%
Sales Y/Y TTM1.38%
EPS Q/Q234.02%
Sales Q/Q0.52%
EarningsNov 04 AMC
EPS/Sales Surpr.19.04% 0.99%

Ownership

Insider Own33.16%
Insider Trans-0.01%
Inst Own71.34%
Inst Trans-8.73%
ROA9.99%
ROE14.27%
ROIC11.99%
Gross Margin52.20%
Oper. Margin9.48%
Profit Margin39.45%
SMA204.12%
SMA503.44%
SMA20022.37%
Trades-

Technical

Shs Outstand21.83M
Shs Float17.98M
Short Float6.43%
Short Ratio4.52
Short Interest1.16M
52W High396.23 -2.46%
52W Low236.73 63.26%
Volatility4.17% 3.38%
ATR (14)13.19
RSI (14)58.15
Beta1.05
Rel Volume0.00
Avg Volume255.86K
Volume0

Performance

Perf Week3.09%
Perf Month6.05%
Perf Quarter6.74%
Perf Half Y59.89%
Perf YTD27.56%
Perf Year25.73%
Perf 3Y27.11%
Perf 5Y-47.34%
Perf 10Y128.21%
Recom3.00
Target Price395.00
Prev Close386.48
Price386.48
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
May 15, 2026ResumedRRBC Capital MktsOutperform$320-17.2%
Apr 07, 2026DowngradeCCitigroupBuy → Neutral$300-22.4%
Oct 01, 2024UpgradeCCitigroupNeutral → Buy$350 → $400+3.5%
Aug 28, 2024InitiatedWWells FargoEqual Weight$340-12.0%
Jun 03, 2024ResumedJJefferiesHold$315-18.5%
Apr 03, 2024DowngradeCCitigroupBuy → Neutral$400 → $365-5.6%
Dec 07, 2023InitiatedUUBSBuy$395+2.2%
Jun 16, 2023InitiatedWWells FargoOverweight$550+42.3%
Dec 07, 2022InitiatedRRBC Capital MktsOutperform$565+46.2%
Aug 25, 2022InitiatedCCredit SuisseOutperform$715+85.0%

Peers

Mkt cap
TickerCompanyMkt cap
BRKRBruker Corp9.66B
QGENQiagen NV10.39B
RVTYRevvity Inc17.85B
TXG10x Genomics Inc8.47B
AAgilent Technologies Inc50.18B
DHRDanaher Corp165.12B
TMOThermo Fisher Scientific Inc265.76B
TECHBio-Techne Corp11.41B
QDELQuidelOrtho Corp790.42M
WATWaters Corp46.74B

Insider trading

latest 14 of 36
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
COURTNEY ENLOEOfficerNov 10 '26Proposed Sale386.17902348,321Nov 10 05:20 PM
JONATHAN DIVINCENZOOfficerNov 09 '26Proposed Sale390.47919358,842Nov 09 05:28 PM
JAMES BARRYOfficerNov 09 '26Proposed Sale385.631,400539,877Nov 09 04:19 PM
DiVincenzo Jonathan P.President & COOOct 24 '26Option Exercise0.001,86903,832Oct 27 04:57 PM
EVRAN SEDATEVP, Global Supply ChainOct 20 '26Option Exercise0.001,04404,647Oct 22 05:55 PM
Allison SchwartzDirectorSep 06 '26Option Exercise0.009201,768Sep 09 06:47 PM
Allison SchwartzDirectorSep 05 '26Option Exercise0.0022801,758Sep 09 06:47 PM
BARRY JAMESEVP, President, LSGSep 06 '26Option Exercise0.001,05602,495Sep 09 06:46 PM
BARRY JAMESEVP, President, LSGSep 05 '26Option Exercise0.001,02701,808Sep 09 06:46 PM
EVRAN SEDATEVP, Global Supply ChainSep 06 '26Option Exercise0.0086403,880Sep 09 06:46 PM
EVRAN SEDATEVP, Global Supply ChainSep 05 '26Option Exercise0.001,02703,345Sep 09 06:46 PM
ENGELHARDT EVA ANETTEEVP, President, CDGSep 06 '26Option Exercise0.001,15202,313Sep 09 06:45 PM
ENGELHARDT EVA ANETTEEVP, President, CDGSep 05 '26Option Exercise0.001,02701,530Sep 09 06:45 PM
DiVincenzo Jonathan P.President & COOSep 05 '26Option Exercise0.001,71202,631Sep 09 06:45 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.95B
VTIVanguard Morningstar Total Stock Market ETFAUM: 689.41B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.54B
VBVanguard Morningstar Small-Cap ETFAUM: 79.96B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.82B
VXFVanguard Extended Market Index ETFAUM: 30.61B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.57B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.35B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.97B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.29B

News

latest 14 of 206
  • Bio-Rad Returns To Currency-Neutral Growth As Margin Gains Carry A Modest EPS Beat; Top Line Still Falls Short (Earnings Whispers)
  • Bio-Rad: Q3 Earnings Snapshot (Associated Press)
  • Bio-Rad to Participate in Fireside Chat During UBS Global Healthcare Conference (Business Wire)
  • Bio-Rad's Rally Puts Pressure On Q3 To Prove Life Science Bottom And Margin Recovery (Earnings Whispers)
  • Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher (InvestorsHub)
  • Loading…
  • Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum (Business Wire)
  • ILMN Stock Keeps Climbing. Should You Climb On? (Trefis)
  • Bio-Rad to Participate in Fireside Chat During Wells Fargos 21st Annual Healthcare Conference (Business Wire)
  • Bio-Rad Laboratories Inc (BIO) (Q2 2026) Earnings Call Highlights: Digital PCR Surges 20%+ as ... (GuruFocus.com)
  • Bio-Rad: Q2 Earnings Snapshot (Associated Press)
  • Bio-Rad Reports Second-Quarter 2026 Financial Results (Business Wire)
  • Avantor Stock Surged Because One Segment Stopped Shrinking (Trefis)
  • Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-042.6502.22617.020656.4649.942
2026Q22026-08-042.6201.74813.851651623.994
2026Q12026-04-301.8901.973-19.553592.1589.914
2025Q42026-02-122.5102.70826.655693.2688.815
2025Q32025-10-292.2601.954-12.699653652.245
2025Q22025-07-312.6101.73411.672651.6615.26
2025Q12025-05-012.5401.8102.289585.4573.276
2024Q42025-02-132.9002.868-25.567667.5679.296
2024Q32024-10-302.0101.15723.340649.73628.186
2024Q22024-08-013.1102.015-76.263638.48645.795
2024Q12024-05-072.2902.14613.453610.8619.095
2023Q42024-02-153.1002.81812.136681.186855
2023Q32023-10-262.3302.7823.636632.12689.55
2023Q22023-08-033.0002.679-39.593681.11697.966
2023Q12023-05-043.3403.5422.318676.84689.965
2022Q42023-02-163.3103.44827.784730.29742.265

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY7.0607.21058.2652,3122,329
2020FY10.5209.810126.22,5462,443
2021FY15.66015.309140.832,9232,886
2022FY14.42014.395-121.792,8022,816
2023FY11.78011.484-21.8192,6712,676
2024FY10.31010.283-65.3652,5672,578
2025FY9.92010.11527.8502,5832,579
2026FY-9.983--2,588
2027FY-10.485--2,645
2028FY-11.877--2,722
2029FY-13.270--2,796
2030FY-14.920--2,875

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06201688.66686.71690.6
2026Q4S2026-11-05201688.65686.7690.6
2026Q4S2026-11-04200695.42691.6699.25
2026Q4S2026-10-23200695.42691.6699.25
2026Q4S2026-10-19200695.4691.6699.2
2026Q4S2026-10-14202695.4691.6699.2
2026Q4S2026-09-28202695.42691.6699.25
2026Q4S2026-09-25303689.42677.4699.25
2026Q4S2026-09-09404689.91677.4699.25
2026Q4S2026-08-05404689.9677.4699.2
2026Q4S2026-08-01400708.85698.3716.68
2026Q4S2026-07-15401708.85698.3716.68
2026Q4S2026-05-21402708.85698.3716.68
2026Q4S2026-05-18402709.85702.3716.68

Estimate history

EPS, annual4.0712.09558.265126.203140.832-121.791-21.819-65.36527.85537.973
Period201720182019202020212022202320242025TTM
EPS, quarterly23.34-25.5672.28911.672-12.69926.655-19.55313.85117.02
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2160.1532289.4152311.6592545.6262922.5452802.2492671.2622566.52583.22592.7
Period201720182019202020212022202320242025TTM
Sales, quarterly649.729667.5585.4651.6653693.2592.1651656.4
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual29.78529.829.92529.84429.93229.59628.51828.01126.9926.891
Period201720182019202020212022202320242025MRQ
Shares, quarterly27.99628.01127.63327.06226.97426.9926.82826.73826.891
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,592.702,583.202,566.502,671.262,802.252,922.552,545.632,311.662,289.41
Cost of Goods Sold Incl. D&A1,239.401,239.601,187.601,239.921,233.821,259.451,109.701,050.261,066.36
Gross Profit1,353.301,343.601,378.901,431.351,568.431,663.101,435.921,261.401,223.05
Selling, General and Administrative Excl. Other1,107.401,077.501,067.901,047.551,089.111,098.361,030.771,007.431,040.28
Research and Development250.40257.60253.90226.93256.79247.34227.80196.71199.20
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income245.90266.10311.00383.80479.32564.74405.16253.96182.77
Interest Expense48.8049.0048.9049.4438.111.5521.8623.4223.96
Unusual Expense-1,029.70-681.502,698.801,295.755,208.25-4,861.05-4,497.02-2,002.39-319.32
Net Income Before Taxes1,320.20995.50-2,342.50-850.10-4,704.275,449.064,907.642,261.08512.66
Income Taxes297.30235.60-498.30-212.78-1,076.741,194.801,101.37502.41147.04
Consolidated Net Income1,022.90759.90-1,844.20-637.32-3,627.534,254.263,806.271,758.67365.61
Net Income From Continuing Operations1,022.90759.90-1,844.20-637.32-3,627.534,254.263,806.271,758.67365.61
Net Income1,022.90759.90-1,844.20-637.32-3,627.534,254.263,806.271,758.67365.61
EPS (Recurring)11.2110.371.599.230.6128.1921.8311.834.70
EPS (Basic, Before Extraordinaries)38.1527.87-65.36-21.82-121.79142.61127.8658.9312.25
EPS (Diluted)37.9727.85-65.36-21.82-121.79140.83126.2058.2712.10
EBITDA449.90471.50503.80576.20656.52741.64580.36428.46320.87
Non-Operating Income (Expense)93.4096.9094.20111.2962.7824.8227.3228.1534.53
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense48.1148.7051.7051.5052.1043.8035.6030.0023.40
Price To Earnings Ratio10.1810.18---5.394.616.3519.94
Price To Sales Ratio3.933.203.613.534.477.816.914.833.07
Gross Margin52.2052.0153.7353.5855.9756.9156.4154.5753.42
Operating Margin9.4810.3012.1214.3717.1019.3215.9210.997.98
Net Margin39.4529.42-71.86-23.86-129.45145.57149.5276.0815.97
Shares Outstanding26.8926.9928.0128.5229.6029.9329.8429.9329.80
Market Capitalization10,393.5710,393.579,197.239,410.6912,540.7422,605.3717,389.3911,076.856,958.01

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue656.40651.00592.10693.20653.00651.60585.40667.50
Cost of Goods Sold Incl. D&A303.10305.20282.70348.40310.20306.20274.80312.40
Gross Profit353.30345.80309.40344.80342.80345.40310.60355.10
Selling, General and Administrative Excl. Other276.00273.20275.30282.90276.40265.90253.70270.30
Research and Development60.3061.2062.9066.0070.6060.8060.2067.80
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income77.3072.6034.1061.9066.4079.5056.9084.80
Interest Expense12.3012.1012.3012.1012.3012.6012.0012.20
Unusual Expense-461.20-458.00738.20-848.70497.80-332.001.401,002.90
Net Income Before Taxes538.70542.10-689.80929.20-431.10414.0083.40-908.90
Income Taxes80.10170.70-162.70209.20-89.2096.2019.40-193.10
Consolidated Net Income458.60371.40-527.10720.00-341.90317.8064.00-715.80
Net Income From Continuing Operations458.60371.40-527.10720.00-341.90317.8064.00-715.80
Net Income458.60371.40-527.10720.00-341.90317.8064.00-715.80
EPS (Recurring)5.041.89-0.384.660.243.142.32-0.49
EPS (Basic, Before Extraordinaries)17.1213.89-19.5526.69-12.7011.672.29-25.57
EPS (Diluted)17.0213.85-19.5526.65-12.7011.672.29-25.57
EBITDA127.70123.2084.70114.30120.60130.10105.10134.10
Non-Operating Income (Expense)12.5023.6026.6030.7012.6015.1039.9021.40
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense12.2411.4611.8512.5611.779.4012.0912.93
Price To Earnings Ratio10.1848.339.99-23.89---
Price To Sales Ratio3.933.042.903.172.952.572.683.58
Gross Margin53.8253.1252.2549.7452.5053.0153.0653.20
Operating Margin11.7811.155.768.9310.1712.209.7212.70
Net Margin69.8757.05-89.02103.87-52.3648.7710.93-107.24
Shares Outstanding26.8926.7426.8326.9926.9727.0627.6328.01
Market Capitalization10,393.577,857.477,523.578,173.097,588.056,566.946,822.389,197.23

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments1,542.701,665.901,612.851,796.24875.491,000.671,120.30850.47761.42
Short Term Receivables472.50465.60500.92506.25425.74419.42392.67392.44464.85
Inventories740.70760.00780.52719.32572.24622.25554.01583.82594.80
Other Current Assets150.30138.80154.04136.17117.0197.49113.18196.75155.58
Total Current Assets2,906.203,030.303,048.333,157.981,990.482,139.842,180.162,023.481,976.65
Net Property, Plant & Equipment709.90688.60723.74679.56716.44693.51701.21508.69493.50
Total Investments and Advances6,104.004,839.507,698.478,831.2114,387.349,562.064,640.092,658.241,028.01
Intangible Assets754.10704.10734.08738.63601.28491.41409.66352.89680.18
Other Assets102.30101.6094.4594.28103.8585.8177.7567.7794.67
Total Assets10,576.509,364.1012,299.0713,501.6717,799.3912,972.628,008.865,611.074,273.01
Short Term Debt Incl. Current Port. of LT Debt37.9043.3041.3737.3037.4238.30461.540.490.42
Accounts Payable129.00122.30142.82134.94141.94139.45107.01122.45135.18
Income Tax Payable36.6031.20-11.9310.3223.288.7627.5119.80
Other Current Liabilities313.50271.00338.61384.54491.25430.50328.18300.34347.29
Total Current Liabilities517.00467.80522.80568.71680.94631.54905.50450.80502.70
Long Term Debt1,347.401,331.801,364.531,361.41196.95198.39189.60438.94434.58
Provision for Risks Charges0.000.000.900.000.0094.9083.205.2014.00
Deferred Tax Liabilities1,059.40818.001,475.491,770.483,064.582,076.78997.79553.24222.21
Other Liabilities199.10177.20194.21185.81171.6991.0777.72142.57169.28
Total Liabilities3,122.902,794.803,557.943,886.414,114.163,092.682,253.801,590.741,342.76
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7,453.606,569.308,741.139,615.2513,685.249,879.945,755.064,020.332,930.25
Total Shareholders Equity7,453.606,569.308,741.139,615.2513,685.249,879.945,755.064,020.332,930.25
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7,453.606,569.308,741.139,615.2513,685.249,879.945,755.064,020.332,930.25
Total Liabilities & Stockholders Equity10,576.509,364.1012,299.0713,501.6717,799.3912,972.628,008.865,611.074,273.01
Book Value Per Share276.16234.52306.51324.89457.20331.05192.31134.9198.38
Tangible Book Value Per Share248.22209.39280.77299.93437.12314.59178.62123.0775.54
Full-Time Employees7,4507,7008,0308,2007,9008,0008,1208,2608,150
Price to Book Ratio1.371.231.121.481.651.761.921.722.49
Return on Assets7.62-17.03-4.94-23.2027.6536.2825.837.403.01
Return on Equity10.84-24.09-6.94-31.1636.1148.6935.9810.524.44
Return on Invested Capital8.63-23.34-6.31-33.0530.6537.7729.588.203.63
Quick Ratio4.194.854.344.292.082.401.803.192.75
Current Ratio5.626.485.835.552.923.392.414.493.93

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,022.90759.90-1,844.20-637.32-3,627.534,254.263,806.271,758.67365.61
Depreciation204.00205.40192.80192.40177.20176.90175.20174.50138.10
Other Funds (Non Cash)-1,270.80-879.202,675.701,270.105,234.40-4,914.90-4,498.40-2,030.10-300.09
Funds from Operations206.90256.60397.50502.581,784.07-483.74-516.93353.27324.53
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital261.20275.6057.10-127.63-348.0268.31113.36104.62-39.03
Income Taxes Payable-0.901.5024.10-21.30-1.20-28.8039.00-4.20-20.90
Cash from Operating Activities468.10532.20454.60374.941,436.05-415.44-403.57457.90285.49
Capital Expenditures-139.00-157.60-165.60-156.68-114.16-133.75-98.92-98.53-129.83
Net Assets From Acquisitions1.10-218.500.000.00-100.75-125.52-96.660.000.00
Sale of Fixed Assets and Businesses0.000.100.102.711.520.0512.310.1311.28
Purchase or Sale of Investments-995.70-607.30-1,077.30-327.76-1,702.42-510.27119.60-119.30-68.43
Purchase of Investments-816.50-669.30-1,276.60-689.04-2,060.24-851.63-248.46-450.84-370.75
Sale Or Maturity of Investments-179.2062.00199.30361.28357.81341.36368.06331.53302.32
Other Uses0.000.00-23.400.000.00-453.440.000.000.00
Other Sources793.60793.601,106.00501.94708.21425.543.418.820.00
Cash from Investing Activities-340.00-189.70-160.2020.21-1,207.59-797.38-60.25-208.89-186.98
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-64.20-279.70-184.40-410.24-198.12-29.37-79.81-11.06-34.78
Repurchase of Common Pref Stock-79.30-295.50-203.60-428.73-215.68-50.00-100.00-28.00-48.91
Sale of Common Pref Stock15.1015.8019.2018.4817.5620.6320.2016.9414.13
Proceedsfrom Stock Options3.9015.8019.2018.4817.5620.6320.2016.9414.13
Issuance or Reduction of Debt, Net-0.60-0.50-0.40-0.471,185.71-3.02-426.94-0.64-2.96
Change in Long Term Debt-0.60-0.50-0.40-0.471,185.71-3.02-426.94-0.64-2.96
Issuance of Long Term Debt0.000.000.000.001,186.220.000.000.000.00
Reduction of Long Term Debt-0.60-0.50-0.40-0.47-0.51-3.02-426.94-0.64-2.96
Net Financing Active Other Cash Flow-5.10-3.00-33.40-14.94-14.02-23.04-16.30-11.06-10.94
Other Financing Activities Uses-5.60-3.00-33.40-14.94-14.02-23.04-16.30-11.06-10.94
Cash from Financing Activities-69.90-283.20-218.20-425.65973.58-55.43-523.04-22.76-48.68
Exchange Rate Effect10.70-16.909.200.322.98-12.6412.432.24-0.66
Net Change in Cash68.9042.4085.40-30.18-36.59-195.984.46228.4949.18
Free Cash Flow329.10374.60289.00218.261,323.27-549.18-502.49359.37155.67
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow30.9222.0732.0743.219.46--31.0845.09
Deferred Taxes & Investment Tax Credit-170.50-626.80-322.600.000.000.00450.20120.90

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,665.901,620.101,566.301,542.701,420.601,375.80
Short Term Receivables433.30450.70439.50472.50474.20478.00
Inventories783.90780.60770.50740.70783.20798.80
Other Current Assets195.50169.10165.80150.30164.00158.50
Total Current Assets3,078.603,020.502,942.102,906.202,842.002,811.10
Net Property, Plant & Equipment652.80671.90689.40709.90720.50740.10
Total Investments and Advances6,273.405,723.805,312.006,104.005,058.205,576.90
Intangible Assets677.40734.30743.90754.10967.10978.50
Other Assets100.90101.50102.60102.30108.60107.50
Total Assets10,783.1010,252.009,790.0010,576.509,696.4010,214.10
Short Term Debt Incl. Current Port. of LT Debt432.70434.30436.7037.9038.1040.60
Accounts Payable133.50143.50133.10129.00128.80139.30
Income Tax Payable37.8074.2044.9036.6044.8036.20
Other Current Liabilities365.10309.30302.30313.50310.60332.80
Total Current Liabilities969.10961.30917.00517.00522.30548.90
Long Term Debt930.70936.10941.501,347.401,357.201,365.90
Provision for Risks Charges15.500.000.000.000.000.00
Deferred Tax Liabilities1,089.40982.20881.801,059.40872.60961.00
Other Liabilities175.40198.50198.40199.10207.50209.60
Total Liabilities3,180.103,078.102,938.703,122.902,959.603,085.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity7,603.007,173.906,851.307,453.606,736.807,128.70
Total Shareholders Equity7,603.007,173.906,851.307,453.606,736.807,128.70
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity7,603.007,173.906,851.307,453.606,736.807,128.70
Total Liabilities & Stockholders Equity10,783.1010,252.009,790.0010,576.509,696.4010,214.10
Book Value Per Share282.73268.30255.37276.16249.75263.42
Tangible Book Value Per Share257.54240.84227.65248.22213.90227.26
Full-Time Employees---7,400--
Price to Book Ratio1.371.151.011.211.061.00
Return on Assets9.992.171.757.62-6.663.21
Return on Equity14.273.112.5010.84-9.504.59
Return on Invested Capital5.374.58-6.768.18-4.223.74
Quick Ratio2.372.332.374.193.943.67
Current Ratio3.183.143.215.625.445.12

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income458.60371.40-527.10720.00-341.90317.80
Depreciation50.4050.6050.6052.4054.2050.60
Other Funds (Non Cash)-522.10-443.50753.20-1,058.40511.40-317.30
Funds from Operations104.7087.30110.70-95.80135.30120.60
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-8.3011.40-2.60260.70-14.40-4.10
Income Taxes Payable-52.2047.90-10.2013.600.40-18.20
Cash from Operating Activities96.4098.70108.10164.90120.90116.50
Capital Expenditures-31.20-32.00-30.00-45.80-31.70-45.70
Net Assets From Acquisitions0.001.100.000.00-1.80-216.70
Sale of Fixed Assets and Businesses0.00-0.100.100.000.000.10
Purchase or Sale of Investments-114.70-35.70-63.30-782.00-9.50146.90
Purchase of Investments-267.40-184.20-226.10-138.80-223.90-153.20
Sale Or Maturity of Investments152.70148.50162.80-643.20214.40300.10
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.00793.600.000.00
Cash from Investing Activities-145.90-66.70-93.20-34.20-43.00-115.40
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.60-27.30-44.403.90-50.00-136.00
Repurchase of Common Pref Stock0.00-31.50-47.800.00-53.40-140.20
Sale of Common Pref Stock3.604.203.403.903.404.20
Proceedsfrom Stock Options0.000.000.003.903.404.20
Issuance or Reduction of Debt, Net-0.10-0.20-0.10-0.200.00-0.20
Change in Long Term Debt-0.10-0.20-0.10-0.200.00-0.20
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.10-0.20-0.10-0.200.00-0.20
Net Financing Active Other Cash Flow-5.10-0.100.50-0.40-2.50-0.10
Other Financing Activities Uses-5.10-0.100.00-0.40-2.50-0.10
Cash from Financing Activities-1.60-27.60-44.003.30-52.50-136.30
Exchange Rate Effect-0.605.405.900.001.10-16.20
Net Change in Cash-51.709.80-23.20134.0026.50-151.40
Free Cash Flow65.2066.7078.10119.1089.2070.80
Price to Free Cash Flow30.9222.3021.0421.8522.4217.71

Revenue breakdown

Americas2024: 169.30M 2025: 165.40M
Asia Pacific2024: 521.60M 2025: 513.30M
Europe2024: 834.10M 2025: 881.80M
United States2024: 1.04B 2025: 1.02B
Clinical Diagnostics2024: 1.54B 2025: 1.56B
Life Science2024: 1.03B 2025: 1.02B
Other Operating2024: 500.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.43%1.2M18.0M254.34K
2026-10-156.15%1.1M17.9M273.62K
2026-09-306.63%1.2M17.8M279.83K
2026-09-155.60%1.0M17.8M294.99K
2026-08-316.33%1.1M17.9M309.31K
2026-08-147.43%1.3M17.9M356.16K
2026-07-317.90%1.4M17.9M386.73K
2026-07-158.72%1.6M17.9M381.69K
2026-06-308.49%1.5M17.9M376.99K
2026-06-158.51%1.5M17.9M376.97K
2026-05-298.40%1.5M17.9M364.55K
2026-05-157.48%1.3M17.9M325.94K
2026-04-306.09%1.1M17.9M303.43K
2026-04-155.90%1.1M18.1M295.23K
2026-03-316.71%1.2M18.1M290.85K
2026-03-135.57%1.0M18.1M253.45K
2026-02-275.24%0.9M18.1M233.29K
2026-02-135.26%1.0M18.1M214.62K
2026-01-304.53%0.8M18.1M190.58K
2026-01-154.38%0.8M18.1M204.75K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call240144.51520.002.3000.000.000.965-0.4590.049
call2501341420.002.0290.000.000.963-0.4530.052
call2601241320.001.9890.000.000.960-0.4460.055
call2701141220.001.8420.000.000.950-0.5080.066
call2801041120.001.6020.000.000.910-0.8900.103
call29094.0010277.531.4671.000.000.902-0.8670.110
call30084.0092.000.001.3360.000.000.894-0.8420.116
call31074.0082.000.001.2070.000.000.884-0.8140.124
call32065.0071.400.001.0320.000.000.872-0.7820.133
call33054.0062.000.001.0250.000.000.858-0.7470.143
call34044.1052.000.000.8300.000.000.841-0.7060.154
call35035.0043.000.000.7640.000.000.818-0.6580.168
call36026.0033.7031.960.6670.000.000.729-0.9170.211
call37017.4024.900.000.5810.000.000.684-0.7960.226
call38010.0018.0018.300.5704.000.000.595-0.7330.246
call3904.5013.0013.800.57113.000.000.483-0.7270.253
call4000.1010.000.000.5980.000.000.389-0.7320.244
call4100.0510.000.050.7340.000.000.331-0.8260.231
call4200.004.900.390.6221.000.000.224-0.6060.190
call4300.004.900.000.7120.000.000.204-0.6600.180
call4400.004.900.000.8050.000.000.186-0.7040.170
call4500.004.900.000.8920.000.000.172-0.7420.162
call4600.001.700.000.7260.000.000.084-0.3660.098
call4700.001.900.000.7930.000.000.079-0.3790.093
call4800.001.900.000.8570.000.000.074-0.3900.089
call4900.001.900.000.9190.000.000.070-0.4000.085
call5000.001.900.000.9850.000.000.066-0.4110.081
call5100.001.900.001.0360.000.000.063-0.4190.079
call5200.001.900.001.0980.000.000.061-0.4270.076
put2400.001.900.001.7420.000.00-0.035-0.4320.049
put2500.001.900.001.6210.000.00-0.037-0.4250.052
put2600.001.700.001.4840.000.00-0.041-0.4140.055
put2700.002.100.001.4430.000.00-0.050-0.4790.066
put2800.004.900.001.6380.000.00-0.091-0.8580.103
put2900.004.900.621.5025.000.00-0.098-0.8330.110
put3000.004.900.001.3750.000.00-0.106-0.8090.116
put3100.004.902.501.24556.000.00-0.116-0.7800.124
put3200.004.902.391.1160.000.00-0.128-0.7470.133
put3300.004.905.520.98970.000.00-0.142-0.7110.143
put3400.004.902.450.85511.000.00-0.161-0.6650.155
put3500.004.907.500.7351.000.00-0.182-0.6210.168
put3600.1010.000.000.8490.000.00-0.275-0.8760.211
put3700.1010.005.070.69375.005.00-0.322-0.7580.227
put3803.0011.0015.000.5784.000.00-0.399-0.7100.245
put3907.5015.000.000.5420.000.00-0.509-0.6850.254
put40012.0021.000.000.5430.000.00-0.611-0.6890.244
put41020.4028.000.000.5410.000.00-0.669-0.7800.231
put42029.0037.000.000.6020.000.00-0.773-0.5600.192
put43039.0046.000.000.6420.000.00-0.796-0.6130.180
put44049.0056.000.000.7310.000.00-0.814-0.6560.170
put45058.0066.000.000.8150.000.00-0.828-0.6930.162
put46068.0076.600.000.9360.000.00-0.916-0.3160.098
put47078.0086.000.000.9710.000.00-0.921-0.3270.093
put48088.0096.000.001.0440.000.00-0.926-0.3370.089
put49098.001060.001.1140.000.00-0.930-0.3470.085
put500108116.70.001.2370.000.00-0.934-0.3550.082
put510118126.90.001.3190.000.00-0.937-0.3630.079
put520128136.40.001.3440.000.00-0.939-0.3690.076

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-274Statement of changes in beneficial ownership of securities2026-10-24SEC
2026-10-224Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-094Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-07-31SEC
2026-07-284Statement of changes in beneficial ownership of securities2026-07-25SEC
2026-05-28144Filing for proposed sale of securities under Rule 144.SEC
2026-05-134Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-13SDSpecialized Disclosure ReportSEC
2026-05-11144Filing for proposed sale of securities under Rule 144.SEC
2026-04-30S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-04-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-308-KCurrent report2026-04-30SEC
2026-04-284Statement of changes in beneficial ownership of securities2026-04-24SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500135.60K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1100214.29K1

Institutional holders

Manager% owned
First Eagle Investment Management, LLC9.18%
BlackRock, Inc.6.35%
DIMENSIONAL FUND ADVISORS LP3.31%
VANGUARD CAPITAL MANAGEMENT LLC3.09%
ARIEL INVESTMENTS, LLC3.05%
VANGUARD PORTFOLIO MANAGEMENT LLC3.05%
EARNEST PARTNERS LLC2.17%
STATE STREET CORP2.14%
BANK OF AMERICA CORP /DE/1.83%
Capital World Investors1.73%

Funds

Fund% owned
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND81.48%
Navigator Tactical Fixed Income Fund54.28%
VANGUARD TOTAL BOND MARKET INDEX FUND42.30%
VANGUARD INTERMEDIATE-TERM BOND INDEX FUND26.94%
VANGUARD TOTAL BOND MARKET II INDEX FUND23.22%
iShares 5-10 Year Investment Grade Corporate Bond ETF22.94%
iShares Investment Grade Systematic Bond ETF22.63%
PIMCO Long Duration Credit Bond Portfolio19.51%
Invesco BulletShares 2032 Corporate Bond ETF16.47%
iShares iBonds Dec 2032 Term Corporate ETF15.75%

OakChart. BIO. Cached 15 minutes.